Skip to Content

iRobot Founder’s Startup to Develop UAVs for Bridge Inspection

CyPhy Works receives a $2.4 million grant.

We found out in June that the stealth robotics company created by iRobot founder Helen Greiner would work on unmanned air vehicles (UAVs) for emergency response. Now the company has revealed that these UAVs will also be used to inspect bridges, dams and other infrastructure.

Formerly known as The Droid Works, and now called CyPhy Works, the company has received a National Institute of Standards and Technology (NIST) Technology Innovation Program (TIP) grant of $2.4 million. CyPhy Works will work with researchers at the Georgia Institute of Technology to develop small, hovering UAVs equipped with video cameras and sensors.

According to a press release from the company:

If successful, the project will produce an advanced class of UAVs that would enable entirely novel, efficient, and relatively low-cost techniques for monitoring the health of the nation’s existing civil infrastructure.

While many researchers are working on small, hovering robots for search-and-rescue, surveillance, and structure monitoring, controlling and coordinating these aircraft remains a challenge. Many UAV projects currently use GPS to navigate, but this is not very precise and does not work inside buildings.

CyPhy Works apparently plans to develop a more precise navigation system. It has plans for two types of monitoring: Robotic Assisted Inspection, where a UAV slowly flies along a structure taking high resolution images, and Autonomous Robotic Monitoring, where a UAV stays at a structure and routinely checks for potential dangerous changes on its own. It will be interesting to see if the company can make the latter approach work, and what techniques it develops for stabilizing the UAVs in high wind.

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.